Top gappers on : SLN, YMAT and FRGT
Market Analysis
SLN: A $20 Cash Acquisition Agreement and the Uncertainty Between Quote and Completion
How SLN’s signed cash acquisition changes the comparison between a stock quote, an offer and completion risk.

Rank 1SLNSilence Therapeutics plc
- Opening gap
- +125.63%
- Day
- +125.58%
- HOD (ET)
- 19.6608:46 ET
- Est. turnover
- $1.4B
- Gap-ups (≥1M shares)
- 914
Data to the close of October 19, 2026 (ET). Sources checked October 20, 2026.
Silence Therapeutics (SLN) announced a signed agreement for a cash acquisition at $20.00 per American Depositary Share (ADS). A cash offer changes the question behind a stock chart: the quoted price can become closely tied to a contractual payment, a timetable and conditions that have not yet been met.
